Pressure BioSciences, Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch PBIO and buy or sell other stocks, ETFs, and their options commission-free!

About PBIO

Pressure BioSciences, Inc. engages in the manufacture and distribution of infectious disease diagnostic products. It provides pressure-based platform solutions for the worldwide life sciences industry. 

CEO
Richard T. Schumacher
CEORichard T. Schumacher
Employees
16
Employees16
Headquarters
Canton, Massachusetts
HeadquartersCanton, Massachusetts
Founded
1978
Founded1978
Employees
16
Employees16

PBIO Key Statistics

Market cap
20.48K
Market cap20.48K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.30K
Average volume2.30K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.20
52 Week high$0.20
52 Week low
$0.0001
52 Week low$0.0001

Stock Snapshot

As of today, Pressure BioSciences, Inc. Common Stock(PBIO) shares are valued at $0.00. The company's market cap stands at 20.48K.

Pressure BioSciences, Inc. Common Stock(PBIO) stock opened on 2026-03-11 at —. The price climbed to — and dipped to —.

Pressure BioSciences, Inc. Common Stock(PBIO) shares are trading with a volume of 0, against a daily average of 2.3K.

In the last year, Pressure BioSciences, Inc. Common Stock(PBIO) shares hit a 52-week high of $0.20 and a 52-week low of $0.00.

In the last year, Pressure BioSciences, Inc. Common Stock(PBIO) shares hit a 52-week high of $0.20 and a 52-week low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.